Type Whole antibody Target CD40 Synonyms SGN-40 | Source Humanized (from mouse) ATC code none CAS Number 880486-59-9 | |
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.
This drug was developed by Seattle Genetics, Inc.
References
Dacetuzumab Wikipedia(Text) CC BY-SA